Menopause: A Gateway to Heart Disease?

A new study unveiled at the European Society of Cardiology's annual meeting in London reveals that menopause triggers a shift in women's cholesterol levels, potentially setting the stage for heart disease. The research indicates that during menopause, 'bad' LDL cholesterol increases while 'good' HDL cholesterol decreases, creating a lipoprotein profile that could heighten the risk of cardiovascular disease, such as coronary artery disease. Heart disease accounts for 40% of all female deaths, and women typically develop heart disease approximately 10 years later than men, with the risk surging dramatically after menopause. However, the exact reason for this increase in risk has remained elusive. To shed light on this matter, researchers analyzed blood cholesterol levels in 1,246 women and 1,346 men involved in a long-term heart health study.

The study findings showed that all three groups of women experienced an increase in 'bad' LDL cholesterol during menopause. However, the most significant change occurred between menopause and postmenopause, with LDL cholesterol levels jumping by 8.3%. Additionally, postmenopausal women faced a 4.8% decline in 'good' HDL cholesterol. Comparatively, menopausal women had a staggering 213% increase in 'bad' LDL cholesterol. These findings suggest that menopause is associated with unfavorable changes in lipoprotein profiles, with the most pronounced changes found in increases in 'bad' LDL-particles. Further research is necessary to determine if these cholesterol changes directly contribute to greater heart health risk.

Actions